These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9879834)

  • 21. Human reduced folate carrier: translation of basic biology to cancer etiology and therapy.
    Matherly LH; Hou Z; Deng Y
    Cancer Metastasis Rev; 2007 Mar; 26(1):111-28. PubMed ID: 17334909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate.
    Yang R; Kolb EA; Qin J; Chou A; Sowers R; Hoang B; Healey JH; Huvos AG; Meyers PA; Gorlick R
    Clin Cancer Res; 2007 May; 13(9):2557-67. PubMed ID: 17473184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells.
    Dixon KH; Lanpher BC; Chiu J; Kelley K; Cowan KH
    J Biol Chem; 1994 Jan; 269(1):17-20. PubMed ID: 8276792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a human alternatively spliced truncated reduced folate carrier increasing folate accumulation in parental leukemia cells.
    Drori S; Sprecher H; Shemer G; Jansen G; Goldman ID; Assaraf YG
    Eur J Biochem; 2000 Feb; 267(3):690-702. PubMed ID: 10651805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
    Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
    Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The reduced folate carrier (RFC-1) gene is expressed in the murine epidermis.
    Sprecher E; Bergman R; Sprecher H; Maor G; Reiter I; Krivoy N; Drori S; Assaraf YG; Friedman-Birnbaum R
    Arch Dermatol Res; 1998 Jul; 290(7):394-6. PubMed ID: 9749995
    [No Abstract]   [Full Text] [Related]  

  • 27. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
    Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
    Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of elevated transforming growth factor-alpha in psoriatic epidermis.
    Turbitt ML; Akhurst RJ; White SI; MacKie RM
    J Invest Dermatol; 1990 Aug; 95(2):229-32. PubMed ID: 2380581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis.
    Campalani E; Arenas M; Marinaki AM; Lewis CM; Barker JN; Smith CH
    J Invest Dermatol; 2007 Aug; 127(8):1860-7. PubMed ID: 17410198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate transport and resistance.
    Moscow JA
    Leuk Lymphoma; 1998 Jul; 30(3-4):215-24. PubMed ID: 9713954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced-folate carrier (RFC) is expressed in placenta and yolk sac, as well as in cells of the developing forebrain, hindbrain, neural tube, craniofacial region, eye, limb buds and heart.
    Maddox DM; Manlapat A; Roon P; Prasad P; Ganapathy V; Smith SB
    BMC Dev Biol; 2003 Jul; 3():6. PubMed ID: 12887734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter.
    Matherly LH; Hou Z
    Vitam Horm; 2008; 79():145-84. PubMed ID: 18804694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of resistance markers to methotrexate predicts clinical improvement in patients with rheumatoid arthritis.
    Wolf J; Stranzl T; Filipits M; Pohl G; Pirker R; Leeb B; Smolen JS
    Ann Rheum Dis; 2005 Apr; 64(4):564-8. PubMed ID: 15345497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variable expression of RFC1 in human leukemia cell lines resistant to antifolates.
    Kobayashi H; Takemura Y; Ohnuma T
    Cancer Lett; 1998 Feb; 124(2):135-42. PubMed ID: 9500202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis.
    Nakashima-Matsushita N; Homma T; Yu S; Matsuda T; Sunahara N; Nakamura T; Tsukano M; Ratnam M; Matsuyama T
    Arthritis Rheum; 1999 Aug; 42(8):1609-16. PubMed ID: 10446858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis.
    Tervaniemi MH; Katayama S; Skoog T; Siitonen HA; Vuola J; Nuutila K; Sormunen R; Johnsson A; Linnarsson S; Suomela S; Kankuri E; Kere J; Elomaa O
    Sci Rep; 2016 Mar; 6():22745. PubMed ID: 26976200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis.
    Otkjaer K; Kragballe K; Funding AT; Clausen JT; Noerby PL; Steiniche T; Iversen L
    Br J Dermatol; 2005 Nov; 153(5):911-8. PubMed ID: 16225599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tight junction components occludin, ZO-1, and claudin-1, -4 and -5 in active and healing psoriasis.
    Peltonen S; Riehokainen J; Pummi K; Peltonen J
    Br J Dermatol; 2007 Mar; 156(3):466-72. PubMed ID: 17300235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organization of the murine reduced folate carrier gene and identification of variant splice forms.
    Brigle KE; Spinella MJ; Sierra EE; Goldman ID
    Biochim Biophys Acta; 1997 Aug; 1353(2):191-8. PubMed ID: 9294013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate.
    Pinard MF; Jolivet J; Ratnam M; Kathmann I; Molthoff C; Westerhof R; Schornagel JH; Jansen G
    Cancer Chemother Pharmacol; 1996; 38(3):281-8. PubMed ID: 8646804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.